Mac Process and Schenck AccuRate To Merge and Be Renamed - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Mac Process and Schenck AccuRate To Merge and Be Renamed



Mac Process, a supplier of pneumatic conveying and air-filtration systems, and Schenck AccuRate, a leader in the manufacture and supply of dry material feeders and weighing technologies, have merged. Both companies are part of the global Schenck Process Group and have integrated their operations in North America under the name Schenck Process.

Manufacturing for Schenck Process will continue in Whitewater, WI and Sabetha, KS and the company headquarters will be located in Kansas City, MO. Integration efforts began in 2012, resulting in streamlined processes between the two operations, which provide pneumatic conveying, filtration, weighing, and feeding systems from one supplier.

Source: Mac Process

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here